Minutes of the Columbia University Seminar on Appetitive Behavior(#529)Date: September 17th, 2009 Speaker's Name and Affiliation:
Seminar Title: "Addictive-like properties of sugar and fat bingeing in rodents" Chair: Harry R. Kissileff, Ph.D. Rapporteur: Kathleen L. Keller, Ph.D. Attendees and their Affiliation:
Summary: (Prepared by the Rapporteur) Obesity is a serious public health problem in the United States. A variety of reasons may explain why people are overweight, but in Dr. Avena's talk, she focused on the idea that high-fat, high-sugar foods are ubiquitous and tasty, and because of this, are often consumed to excess. The question was raised as to whether some people develop "addictive-like" symptoms when placed in an environment where high-fat and high-sugar foods are abundant. It is well known that drugs of abuse can exert "addictive-like" behaviors in both laboratory animals and humans. These include escalation of intake (sometimes in the form of binges), withdrawal signs in the case of opiates, and craving when the substance of abuse is no longer available. The neural circuitry common to both food and drug addiction involves dopamine neurons that originate in the ventral tegmental area and project to the nucleus accumbens and prefrontal cortex. Both drugs of abuse and food increase extracellular dopamine in these brain areas upon administration, and repeated administration results in sensitization to these signals. A difference between the effects of drugs and food on the dopamine system is that dopamine release normally habituates in response to a palatable food that is no longer novel, while the release of dopamine occurs each time a drug of abuse is administered. In addition, acetylcholine release increases during drug withdrawal, or during states of satiety at the end of a meal. In order to study the addictive-like properties of food, Dr. Avena and colleagues have developed an animal model of sugar bingeing. Sprague-Dawley rats are fasted for 12 h followed by 12 h of access to a 10% sugar solution, starting 4 h into the dark phase, for 1 month. This paradigm results in animals that binge on sugar and increase daily intake of sugar throughout the test period. In vivo microdialysis to measure extracellular dopamine and acetylcholine in these animals shows that dopamine release in the nucleus accumbens repeatedly increases in sugar-bingeing rats, but not in controls. This suggest that sugar bingeing can result in the repeated release of dopamine in the nucleus accumbens, which is more like the effect seen in response to drugs of abuse and unlike the waning of dopamine release that would normally be seen in response to food. In addition, acetylcholine rises at the end of a sugar meal for both controls and bingeing animals, but this rise is delayed on day 21 in the sugar-bingeing rat. The next question addressed in this seminar was whether the taste of sugar drives this alteration in dopamine and acetylcholine release. To test this, an animal model of bulimia nervosa was developed, which combined sugar bingeing and sham feeding. The results demonstrated that sham-fed rats have larger binges on sugar compared to the real-fed animals. Further, sham-feeding while bingeing on sucrose resulted in increases nucleus accumbens dopamine release, but acetylcholine failed to rise at the end of the meal in sham-fed, sugar-bingeing rats. This suggests that the taste of sugar is sufficient release accumbens dopamine and attenuate the release of acetylcholine, and perhaps satiety, in sugar-bingeing rats. In addition, other signs of addiction are noted in sugar-bingeing rats. These rats show behavioral and neurochemical signs of withdrawal (precipitated with naloxone or spontaneously) similar to those seen with drugs of abuse. After a 2-week abstinence period, sugar-bingeing animals show enhanced intake of sugar, which suggests that these animals "crave" the sugar. Further, sugar-bingeing rats show a hyperactive response to a low dose of amphetamine and more readily consume alcohol compared to animals that are not sugar-bingers, suggesting that cross-sensitization to drugs of abuse is evident. A final important question addressed by this seminar was whether this model of sugar bingeing can explain the development of some forms of human obesity. In rats, sugar-bingeing does not result in increased body weights, as these animals reduce intake of chow to compensate for the extra calories obtained from the sugar. Other sugars, such as high-fructose corn syrup, may differentially effect body weight regulation. In a model of fat bingeing using a paradigm that is similar to that used to produce sugar bingeing, opiate-like withdrawal signs were not observed. Thus, the differences that exist between sugar and fat bingeing, and the "addictive-like" nature of each, have to be further investigated. Discussion: Q. Do you think that anything that is rewarding can also be addicting?
Q. Anna Rose Childress has an interesting model on relapse susceptibility that is related to the ability to activate GABA systems. Susceptibility to relapse relates to how efficient you are to activation of the GABA system.
Q. Could intoxication be a distinguishing factor in your model, with respect to "food addiction?" People don't become intoxicated by food.
Q. In Kent Berridge's work where you mix and match drugs and food, he shows that with repeated administration you get sensitization. This is very different from the classical addiction model. This repeated injection paradigm never results in tolerance. Maybe the terminology should be changed?
Q. What is the evidence that humans binge on sugars?
Q. What supplier did you use for your Sprague-Dawley's? Some of the Sprague-Dawley's are less resistant to obesity than others.
Q. The data that you are showing now is with sucrose, right?
Q. The ad libitum rat is fed, but the bingeing rat is not, correct?
Q. Is this total food or glucose?
Q. What is time zero?
Q. Do you see a wide variability in sucrose preference?
Q. Do your dopamine levels differ in response to sucrose vs. glucose?
Q. Does this effect occur in relation to amount of sucrose, or is it in response to just the taste of it?
Q. When are you doing the dialysis for measuring dopamine?
Q. How can you control for that?
Q. Do you see a correlation with the concentration of sucrose used?
Q. On day 1, when neophobia might be a factor, do all rats go for the sugar?
Q. When was the test done with naloxone in relation to their food intake?
Q. What happens if on day 22, you don't give them sugar? Do they go through a behavioral withdrawal?
Q. Do you know whether anxious humans or animals binge on sugar?
Q. Can you induce spontaneous withdrawal if you use a dopamine antagonist and then give sugar?
Q. Is there any data showing that High Fructose Corn Syrup causes dopamine release?
Q. Did you try using fat emulsions?
Q. Did you try Ensure?
Q. Isn't there a time induced effect? If you are looking at gene expression (mRNA), this would take 24 hours, but behavioral withdrawal symptoms (e.g., teeth chattering) appear almost immediately.
Q. Food deprivation increases the administration of all drugs of abuse. Have you tried this condition yet?
Q. How does acetylcholine affect fat bingeing?
Q. Your fat bingeing test paradigm is different from your sucrose paradigm, right?
|